Kiniksa Pharmaceuticals International, plc Revenue from Contract with Customer, Excluding Assessed Tax
Kiniksa Pharmaceuticals International, plc (KNSA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $214.27 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $214.27M, a 55.51% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $202.13M, a 64.95% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $180.85M, a 61.17% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $156.80M, a 44.34% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for fiscal 2025 was $677.56M, a 60.09% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for fiscal 2024 was $423.24M, a 56.60% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for fiscal 2023 was $270.26M, a 22.74% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc revenue from contract with customer, excluding assessed tax for fiscal 2022 was $220.18M, a 471.24% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $214.27M 10-Q · filed 2026-04-28 | $416.39M derived: sum of 2 quarters · filed 2026-04-28 | $597.25M derived: sum of 3 quarters · filed 2026-04-28 | $754.04M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $202.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $382.98M derived: sum of 2 quarters · filed 2026-02-24 | $539.78M derived: sum of 3 quarters · filed 2026-02-24 | $677.56M 10-K · filed 2026-02-24 |
| 2025-09-30 | $180.85M 10-Q · filed 2025-10-28 | $337.65M derived: sum of 2 quarters · filed 2025-10-28 | $475.44M 10-Q · filed 2025-10-28 | $597.97M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $156.80M 10-Q · filed 2025-07-29 | $294.58M 10-Q · filed 2025-07-29 | $417.12M derived: sum of 3 quarters · filed 2026-04-28 | $529.33M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $137.78M 10-Q · filed 2026-04-28 | $260.32M derived: sum of 2 quarters · filed 2026-04-28 | $372.54M derived: sum of 3 quarters · filed 2026-04-28 | $481.17M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $122.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $234.75M derived: sum of 2 quarters · filed 2026-02-24 | $343.38M derived: sum of 3 quarters · filed 2026-02-24 | $423.24M 10-K · filed 2026-02-24 |
| 2024-09-30 | $112.21M 10-Q · filed 2025-10-28 | $220.84M derived: sum of 2 quarters · filed 2025-10-28 | $300.70M 10-Q · filed 2025-10-28 | $384.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $108.63M 10-Q · filed 2025-07-29 | $188.49M 10-Q · filed 2025-07-29 | $271.88M derived: sum of 3 quarters · filed 2026-02-24 | $338.93M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $79.86M 10-Q · filed 2025-04-29 | $163.25M derived: sum of 2 quarters · filed 2026-02-24 | $230.30M derived: sum of 3 quarters · filed 2026-02-24 | $301.77M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $83.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $150.44M derived: sum of 2 quarters · filed 2026-02-24 | $221.91M derived: sum of 3 quarters · filed 2026-02-24 | $270.26M 10-K · filed 2026-02-24 |
| 2023-09-30 | $67.05M 10-Q · filed 2024-10-29 | $138.52M derived: sum of 2 quarters · filed 2024-10-29 | $186.86M 10-Q · filed 2024-10-29 | $248.75M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $71.47M 10-Q · filed 2024-07-25 | $119.82M 10-Q · filed 2024-07-25 | $181.70M derived: sum of 3 quarters · filed 2025-02-25 | $280.84M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $48.34M 10-Q · filed 2024-04-25 | $110.23M derived: sum of 2 quarters · filed 2025-02-25 | $209.36M derived: sum of 3 quarters · filed 2025-02-25 | $236.34M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $61.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $161.02M derived: sum of 2 quarters · filed 2025-02-25 | $187.99M derived: sum of 3 quarters · filed 2025-02-25 | $220.18M 10-K · filed 2025-02-25 |
| 2022-09-30 | $99.14M 10-Q · filed 2023-11-02 | $126.11M derived: sum of 2 quarters · filed 2023-11-02 | $158.30M 10-Q · filed 2023-11-02 | $177.04M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $26.97M 10-Q · filed 2023-08-01 | $59.16M 10-Q · filed 2023-08-01 | $77.91M derived: sum of 3 quarters · filed 2024-02-28 | $90.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $32.19M 10-Q · filed 2023-05-04 | $50.93M derived: sum of 2 quarters · filed 2024-02-28 | $63.03M derived: sum of 3 quarters · filed 2024-02-28 | $70.73M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $18.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $30.84M derived: sum of 2 quarters · filed 2024-02-28 | $38.54M derived: sum of 3 quarters · filed 2024-02-28 | $38.54M 10-K · filed 2024-02-28 |
| 2021-09-30 | $12.10M 10-Q · filed 2022-11-03 | $19.80M derived: sum of 2 quarters · filed 2022-11-03 | $19.80M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $7.70M 10-Q · filed 2022-08-04 | $7.70M 10-Q · filed 2022-08-04 |